As filed with the Securities and Exchange Commission on March 21, 2016

 

Registration No. 333-     

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 


 

FORM S-1

 

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

 


 

COMBIMATRIX CORPORATION

(Exact name of Registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of
incorporation or organization)

 

8071
(Primary Standard Industrial
Classification Code Number)

 

47-0899439
(I.R.S. Employer
Identification Number)

 

310 Goddard, Suite 150
Irvine, California 92618
(949) 753-0624

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 

Mark McDonough
Chief Executive Officer
CombiMatrix Corporation
310 Goddard, Suite 150
Irvine, California 92618
(949) 753-0624

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copy to:

 

Parker A. Schweich, Esq.
Dorsey & Whitney LLP
600 Anton Blvd., Suite 2000
Costa Mesa, CA 92626
Telephone: (714) 800-1400
Facsimile: (714) 800-1499

 

M. Ali Panjwani, Esq.
Pryor Cashman LLP
7 Times Square
New York, NY 10036
Telephone: (212) 326-0820
Facsimile: (212) 798-6319

 

APPROXIMATE DATE OF PROPOSED SALE TO THE PUBLIC: As soon as practicable after the effective date of this Registration Statement.

 

If any securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:  x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  x   333-208704

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See definitions of “large accelerated filer,” “accelerated filed,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o

Accelerated filer o

Non-accelerated filer o
(Do not check if a smaller reporting company)

Smaller reporting company x

 

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

Title of each class of securities
to be registered

 

Proposed
maximum
aggregate
offering
price(1)(4)

 

Amount of
registration
fee(4)

 

8,000 Units consisting of:

 

 

 

 

 

(i) 8,000 shares of Series F Convertible Preferred Stock, $0.001 par value

 

$

 

$

 

(ii) 2,067,183 Warrants to purchase up to 2,067,183 shares of Common Stock(2)(5)

 

$

 

$

 

2,067,183 shares of Common Stock issuable upon conversion of the Series F Convertible Preferred Stock(3)(5)

 

$

 

$

 

2,067,183 shares of Common Stock issuable upon exercise of Warrants to purchase Common Stock(3)(4)

 

$

13,306.59

 

$

1.34

 

Total

 

$

13,306.59

 

$

1.34

 

 

(1) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended (the “Securities Act”).

 

(2) No registration fee required pursuant to Rule 457(g) under the Securities Act.

 

(3) Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.

 

(4) An aggregate amount of $18,674,029.52 was registered under Registration Statement No. 333-208704, in connection with which a filing fee of $1,880.48 had been paid assuming that each Warrant was exercisable for one share of Common Stock at an assumed exercise price per share of $4.83. The additional proposed maximum aggregate offering price is calculated based on each Warrant being exercisable for one share of Common Stock at an exercise price per share of $5.17, which is 100% of the consolidated closing bid price of our Common Stock on The NASDAQ Capital Market on March 18, 2016.

 

(5) No additional consideration is payable upon conversion of the Series F Convertible Preferred Stock or upon issuance of the Warrants.

 

THIS REGISTRATION STATEMENT SHALL BECOME EFFECTIVE UPON FILING WITH THE COMMISSION IN ACCORDANCE WITH RULE 462(b) UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

 

 

 



 

EXPLANATORY NOTE AND
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

 

This Registration Statement on Form S-1 is being filed with respect to the registration of the additional proposed maximum aggregate offering price of shares of common stock underlying warrants of CombiMatrix Corporation, a Delaware corporation, pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This Registration Statement includes the registration statement facing page, this page, the signature pages, an exhibit index, an opinion of counsel regarding the legality of the securities being registered and a related consent and the consent of the Registrant’s independent registered public accounting firm. This Registration Statement relates to the Registrant’s Registration Statement on Form S-1 (Registration No. 333-208704), initially filed by the Registrant on December 22, 2015, as subsequently amended and as declared effective by the Securities and Exchange Commission on March 18, 2016. The Registrant is filing this Registration Statement for the sole purpose of increasing the proposed maximum aggregate offering price of shares of common stock underlying warrants to be issued in such offering by $13,306.59. Pursuant to Rule 462(b), the contents of the Registration Statement on Form S-1, as amended (Registration No. 333-208704), including the exhibits and the power of attorney thereto, are incorporated by reference into this Registration Statement.

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

ITEM 16.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

All exhibits filed with or incorporated by reference in the Registration Statement on Form S-1, as amended (Registration No. 333-208704), are incorporated by reference into, and shall be deemed a part of, this Registration Statement, and the following additional exhibits are filed herewith:

 

Exhibit
Number

 

Description

5.1

 

Legal Opinion of Dorsey & Whitney LLP

 

 

 

23.1

 

Consent of Haskell & White LLP

 

 

 

23.2

 

Consent of Dorsey & Whitney LLP (contained in Exhibit 5.1 to this Registration Statement)

 

 

 

24.1

 

Power of Attorney. Incorporated by reference to the signature page included with the Registrant’s Registration Statement on Form S-1, as amended (Registration No. 333-208704).

 

II-1



 

SIGNATURES

 

In accordance with the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irvine, State of California, on March 21, 2016.

 

 

 

COMBIMATRIX CORPORATION

 

 

 

Date: March 21, 2016

 

By:

/s/ MARK MCDONOUGH

 

 

 

Mark McDonough

 

 

 

President and Chief Executive Officer
(Principal Executive Officer)

 

 

 

 

 

 

 

 

Date: March 21, 2016

 

By:

/s/ SCOTT R. BURELL

 

 

 

Scott R. Burell

 

 

 

Chief Financial Officer, Treasurer and Secretary
(Principal Financial and Accounting Officer)

 

In accordance with the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-1 was signed by the following persons in the capacities and on the dates stated:

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ MARK MCDONOUGH

 

President, Chief Executive Officer and Director (Principal Executive Officer)

 

March 21, 2016

Mark McDonough

 

 

 

 

 

 

 

 

/s/ SCOTT R. BURELL

 

Chief Financial Officer, Treasurer and Secretary (Principal Financial and Accounting Officer)

 

March 21, 2016

Scott R. Burell

 

 

 

 

 

 

 

 

*

 

Chairman of the Board

 

March 21, 2016

R. Judd Jessup

 

 

 

 

 

 

 

 

 

*

 

Director

 

March 21, 2016

Robert E. Hoffman

 

 

 

 

 

 

 

 

 

*

 

Director

 

March 21, 2016

Jeremy M. Jones

 

 

 

 

 

 

 

 

 

*

 

Director

 

March 21, 2016

Scott Gottlieb, M.D.

 

 

 

 

 

 

 

 

 

*

 

Director

 

March 21, 2016

Lâle White

 

 

 

 

 

 

 

 

 

*By:

/s/ SCOTT R. BURELL

 

 

 

 

 

Scott R. Burell,

 

 

 

 

 

as Attorney-in-Fact

 

 

 

 

 

 

 

 

 

 

 

II-2




Exhibit 5.1

 

OPINION AND CONSENT OF DORSEY & WHITNEY LLP

 

March 21, 2016

 

CombiMatrix Corporation
310 Goddard, Suite 150
Irvine, California 92618

 

Ladies and Gentlemen:

 

We have acted as counsel to CombiMatrix Corporation, a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of (i) a Registration Statement on Form S-1 (Registration No. 333-208704) (the “Initial Registration Statement”) and (ii) a Registration Statement on Form S-1 to be filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, as amended (the “Act”) (the “462(b) Registration Statement,” and together with the Initial Registration Statement, the “Registration Statements”). This opinion is furnished to you in connection with the filing of the 462(b) Registration Statement with the Commission under the Act in which the Company is registering under the Registration Statements an aggregate of 2,067,183 shares (the “Warrant Shares”) of the Company’s Common Stock, $0.001 par value per share (the “Common Stock”), underlying the warrants (the “Warrants”) and such indeterminate number of additional shares of Common Stock that shall be issuable pursuant to Rule 416 to prevent dilution resulting from stock splits, stock dividends or similar transactions (collectively, the “Securities”). The Securities are to be sold by the Company pursuant to an underwriting agreement (the “Underwriting Agreement”) entered into by and among the Company, on the one hand, and Ladenburg Thalmann & Co. Inc., on the other hand, on behalf of itself and as representative of the several underwriters named therein.

 

For purposes of this opinion, we have examined such documents and reviewed such questions of law as we have considered necessary and appropriate for the purposes of our opinion set forth below. In rendering our opinion, we have assumed the authenticity of all documents submitted to us as originals, the genuineness of all signatures and the conformity to authentic originals of all documents submitted to us as copies. We have also assumed the legal capacity for all purposes relevant hereto of all natural persons and, with respect to all parties to agreements or instruments relevant hereto other than the Company, that such parties had the requisite power and authority (corporate or otherwise) to execute, deliver and perform such agreements or instruments, that such agreements or instruments have been duly authorized by all requisite action (corporate or otherwise), executed and delivered by such parties and that such agreements or instruments are the valid, binding and enforceable obligations of such parties. As to questions of fact material to our opinions, we have relied upon certificates of officers of the Company and of public officials. We also have assumed that the Securities will be issued and sold as described in the Underwriting Agreement, the Registration Statements and the related prospectus, as amended and supplemented through the date of issuance.

 

Based on the foregoing, we are of the opinion that (i) provided that the Warrants have been duly executed and delivered by the Company and duly delivered to the purchasers thereof against payment therefor, the Warrants, when issued and sold pursuant to the terms of the Underwriting Agreement, will constitute the valid and binding obligations of the Company enforceable against the Company in accordance with their terms; and (ii) the Warrant Shares have been duly authorized and if, as, and when the Warrant Shares are issued and delivered by the Company in accordance with the terms of each Warrant and the Company’s Amended and Restated Certificate of Incorporation, as amended and supplemented to date by all amendments and certificates of designation thereto, including, without limitation, the payment in full of applicable consideration, the Warrant Shares will be validly issued, fully paid and nonassessable.

 

Our opinions expressed above are limited to the Delaware General Corporation Law and, as to the enforceability of the Warrants against the Company, the laws of the State of New York.

 



 

Our opinions expressed above with respect to the enforceability of the Warrants are qualified to the extent that they may be subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium or other similar law of general application relating to or affecting creditors’ rights and remedies, including, without limitation, fraudulent conveyance and fraudulent transfer laws, and by general principles of equity, including (without limitation) principles limiting the availability of specific performance or injunctive relief, and concepts of materiality, reasonableness, good faith and fair dealing, and other similar doctrines affecting the enforceability of agreements generally (regardless of whether such enforceability is considered in a proceeding in equity or at law). We express no opinion as to the availability of any equitable or specific remedy upon any breach of the Warrants, or any of the agreements, documents or obligations referred to therein, or to the successful assertion of any equitable defenses, inasmuch as the availability of such remedies or the success of any equitable defense may be subject to the discretion of a court. We also express no opinion herein as to any provision of the Warrants (a) relating to the effect of invalidity or unenforceability of any provision of the Warrants on the validity or enforceability of any other provision thereof, (b) which is in violation of public policy, including, without limitation, any provision relating to indemnification and contribution with respect to securities law matters, or (c) which provides that the terms of the Warrants may not be waived or modified except in writing.

 

To the extent that any opinion relates to the enforceability of the choice of New York law provision contained in the Warrants, the opinion stated herein is subject to the qualification that such enforceability may be subject to, in each case, (i) the exceptions and limitations in New York General Obligations Law sections 5-1401 and 5-1402, and (ii) principles of comity or constitutionality.

 

We consent to the filing of this opinion letter as Exhibit 5.1 to the 462(b) Registration Statement and to the reference to our firm under the caption “Legal Matters” contained in the Prospectus constituting part of the Registration Statements. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or Item 509 of Regulation S-K.

 

This opinion letter is rendered as of the date first written above and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. Our opinion is expressly limited to the matters set forth above and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company or the securities described above.

 

 

Very truly yours,

 

 

 

/s/ DORSEY & WHITNEY LLP

 

2




EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-1 (the “Registration Statement”) of CombiMatrix Corporation (the “Company”) of our report dated February 18, 2016, relating to our audits of the Company’s consolidated financial statements as of December 31, 2015 and 2014, and for each of the years then ended, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, which report includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern. We also consent to the reference to us under the heading “Experts” in the Registration Statement on Form S-1 (File No. 333-208704) incorporated by reference into this Registration Statement.

 

 

 

/s/ HASKELL & WHITE LLP

 

Irvine, California
March 21, 2016

 


Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Combimatrix Corp. (MM) Charts.
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Combimatrix Corp. (MM) Charts.